Immunome Inc (NQ: IMNM )

11.59 +0.12 (+1.05%)

Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Immunome Inc

< Previous 1 2 3 4 5 6 Next >

Why Franklin Covey Shares Are Trading Higher By 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

June 29, 2023

Gainers Sigilon Therapeutics, Inc. (NASDAQ: SGTX) shares climbed 523.8% to $24.25 after Eli Lilly agreed to acquire the company for $14.92/share in cash.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session

June 29, 2023

Via Benzinga

Immunome Inc. (NASDAQ: IMNM) Leading the Way in Thursday Trading Based on Percentage Gain

June 29, 2023

Via Investor Brand Network

Exposures COVID-19

Why Are Immunome Shares Trading Higher Today

June 29, 2023

Immunome Inc (NASDAQ: IMNM) and Morphimmune have announced a merger agreement in

Via Benzinga

Immunome: Q1 Earnings Insights

May 05, 2023

Via Benzinga

Immunome Stock Jumps On Discovery Pact With AbbVie

January 06, 2023

Via Benzinga

IMNM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Immunome, Inc. Is Fair to Shareholders

June 29, 2023

From Halper Sadeh LLC

Via Business Wire

Immunome (NASDAQ: IMNM) and Morphimmune Announce Merger to Develop Best-in-Class Targeted Cancer Therapies

June 29, 2023

Via Spotlight Growth

Exposures Product Safety

Dow Rises Over 100 Points; US GDP Grows 2% In Q1

June 29, 2023

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.37% to 33,977.04 while the NASDAQ rose...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session

June 29, 2023

Via Benzinga

Immunome and Morphimmune Announce Definitive Merger Agreement and Simultaneous Private Placement Investment of $125 Million to Develop Targeted Cancer Therapies

June 29, 2023

From Immunome

Via Business Wire

Immunome's COVID-19 Cocktail Retains Neutralizing Activity Against Omicron Subvariants

July 06, 2022

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session

June 28, 2023

Via Benzinga

Immunome Publishes Preclinical Research Demonstrating that Inhibition of IL-38 Using an Antibody Leads to Anti-Tumor Activity

May 23, 2023

From Immunome, Inc.

Via Business Wire

Immunome Reports First Quarter 2023 Financial Results

May 05, 2023

From Immunome, Inc.

Via Business Wire

Immunome Reports Fourth Quarter and Full Year 2022 Financial Results

March 16, 2023

From Immunome, Inc.

Via Business Wire

Immunome to Present at 13th Annual World ADC London Conference

March 09, 2023

From Immunome, Inc.

Via Business Wire

Immunome Announces Formation of Antibody-Drug Conjugate and T Cell Redirection Advisory Board

February 08, 2023

From Immunome, Inc.

Via Business Wire

AbbVie Briefly Breaks Out After Tapping Immunome In $30 Million Cancer Deal

January 06, 2023

AbbVie is tapping Immunome to help develop new cancer treatments.

Via Investor's Business Daily

Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session

January 06, 2023

Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process.

Via Benzinga

Dow Rises Over 300 Points; US Adds 223,000 Jobs In December

January 06, 2023

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Friday.

Via Benzinga

AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology Targets

January 06, 2023

From Immunome, Inc.

Via Business Wire

Why Leslie's Shares Are Trading Lower By Over 9%? Here Are 60 Stocks Moving In Wednesday's Mid-Day Session

November 30, 2022

Gainers Biophytis S.A. (NASDAQ: BPTS) shares jumped 114% to $0.7496. Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) rose 74.1% to $0.2115.

Via Benzinga

Immunome Reports Third Quarter 2022 Financial Results

November 14, 2022

From Immunome, Inc.

Via Business Wire

Immunome Presents Preclinical Data on Novel Anti-EPN1 Antibody IMM20059 at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting

November 09, 2022

From Immunome, Inc.

Via Business Wire

Immunome Announces Publication in Clinical & Translational Immunology Highlighting B Cell Repertoires in Patients with Breast Cancer

August 23, 2022

From Immunome, Inc.

Via Business Wire

Recap: Immunome Q2 Earnings

August 05, 2022

Immunome (NASDAQ:IMNM) reported its Q2 earnings results on Friday, August 5, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings Immunome beat estimated earnings by...

Via Benzinga

Immunome Reports Second Quarter 2022 Financial Results

August 05, 2022

From Immunome, Inc.

Via Business Wire

Immunome’s COVID-19 Cocktail Retains Neutralizing Activity Against the Most Prevalent Omicron Subvariants* in the US, BA.4/5 and BA.2.12.1

July 06, 2022

From Immunome, Inc.

Via Business Wire

Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday

July 01, 2022

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.